Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH)
Lopes
L F
LF
de Camargo
B
B
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D002675:Child, Preschool; D005047:Etoposide / Q000009:adverse effects*; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000139:chemically induced*; D008297:Male
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide